Showing results (531-540 of 831) with videos related to
Sort By:
Pageof 84
Neuromuscular Disorders : NMD|January 24, 2006
BSCL2 mutations in two Dutch families with overlapping Silver syndrome-distal hereditary motor neuropathyBart P C van de Warrenburg, Hans Scheffer, Jeroen J J van Eijk, et al.IEEE Transactions on Medical Imaging|December 23, 2014
Multi-Center MRI Carotid Plaque Component Segmentation Using Feature Normalization and Transfer LearningArna van Engelen, Anouk C van Dijk, Martine T B Truijman, et al.Neurology|January 2, 2024
Muscle MRI in Patients With Oculopharyngeal Muscular Dystrophy: A Longitudinal StudyRosemarie H M J M Kroon, Johanna G Kalf, Bert J M de Swart, et al.Muscle & Nerve|September 19, 2024
The other face of facioscapulohumeral muscular dystrophy: Exploring orofacial weakness using muscle ultrasoundSanne C C Vincenten, Jeroen L M van Doorn, Sjan Teeselink, et al.Alzheimer'S Research & Therapy|February 14, 2024
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's diseaseShreyasee Das, Marie-Paule E van Engelen, Julie Goossens, et al.Neuroscience|October 3, 2009
Balance control in patients with distal versus proximal muscle weaknessC G C Horlings, U M Küng, B G M van Engelen, et al.Neurology|February 1, 2013
Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophySaskia Lassche, Ger J M Stienen, Tom C Irving, et al.Pediatric Blood & Cancer|September 30, 2017
DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care centerKalene van Engelen, Anita Villani, Jonathan D Wasserman, et al.Trials|May 16, 2020
OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose chest CT (OPTIMACT) trial-statistical analysis planMaadrika M N P Kanglie, Shandra Bipat, Inge A H van den Berk, et al.Environment International|March 14, 2015
The probabilistic aggregate consumer exposure model (PACEM): validation and comparison to a lower-tier assessment for the cyclic siloxane D5Tatsiana Dudzina, Christiaan J E Delmaar, Jacqueline W H Biesterbos, et al.Pageof 84